The Journal of Parkinson’s Disease (JPD), published by IOS Press, has announced that beginning in January 2023, JPD will transition to a Gold Open Access publication. This means that all articles published after that date will be immediately and permanently freely available online for readers to view, download, share, and reuse, and will enable authors to comply more easily with funder and institutional mandates.
With a strong Journal Impact Factor of 5.520 and Cite Score of 6.1, JPD is now recognized as one of the most influential journals in the world devoted exclusively to PD. In recent years the number of open access papers published in JPD has been steadily increasing, so that now approximately half are publicly available. The transition to fully open content will increase the journal’s impact and benefit the entire Parkinson’s disease community, including authors, readers, libraries, hospitals, funding agencies – and ultimately patients.
JPD offers a rigorous peer-review process and operates with rapid manuscript processing times. The average time from submission to first decision is 18 days (the median average is 13 days). Accepted papers submitted from November 1, 2022, will be published Open Access under a Creative Commons license, and authors and will retain copyright to their published work.
The associated open access fee has been set to be extremely competitive compared to those set by other journals in the field. The fee will not apply to certain publication types, like invited articles, editorials, and commentaries. Fees may be waived under certain circumstances, particularly from low-income countries as defined by HINARI, upon application from the authors.
Click here to read the original press release.
